Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
6.3% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
36
users have followed this narrative
Updated
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
0.9% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
22
users have liked this narrative
12
users have commented on this narrative
27
users have followed this narrative
14 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.9% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
20
users have liked this narrative
7
users have commented on this narrative
25
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
43.2% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
16
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
TechnoPro Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Expanding Into Automotive Software Markets Will Drive Future Success
Key Takeaways Expanding solution offerings and strategic price adjustments could improve margins and drive future revenue growth. Investing in training inexperienced engineers and targeting emerging markets may enhance operational capacity and stabilize costs.
View narrative
JP¥3.87k
FV
24.7% overvalued
intrinsic discount
8.51%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
Updated
narrative
Cinclus Pharma Holding
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
PCAB Pipeline Will Revolutionize Severe GERD Treatment Globally
Key Takeaways Innovative drug formulation, strong market demand, and strategic partnerships position Cinclus Pharma for significant revenue and margin growth in both domestic and international markets. Retention of global commercial rights enables flexible licensing or direct launch strategies, supporting long-term earnings potential through multiple income streams.
View narrative
SEK 61.25
FV
74.4% undervalued
intrinsic discount
86.19%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
New
narrative
Valneva
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Rapid Lyme Vaccine Development And Rising Preventative Healthcare Will Shape Future Markets
Key Takeaways Leading vaccine programs and strategic partnerships are set to expand market reach, supporting sustainable growth through innovative, in-demand preventative healthcare solutions. Operational efficiency gains and a robust development pipeline position the company for diversified long-term growth and improved profitability.
View narrative
€7.48
FV
47.5% undervalued
intrinsic discount
23.36%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
13
users have followed this narrative
Updated
narrative
Zedcor
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
US Expansion And AI Monitoring Will Broaden Remote Security Footprint
Key Takeaways Expansion into the U.S. and operational efficiencies position Zedcor to capture market share and drive recurring, high-margin revenue growth. Differentiated AI-enabled solutions and compliance advances will broaden the customer base and support sustained improvement in profitability and earnings stability.
View narrative
CA$5.60
FV
24.1% undervalued
intrinsic discount
62.67%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
New
narrative
NETGEAR
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Expanding ProAV And Cloud Networking Will Raise Stakes Despite Risks
Key Takeaways Shift toward enterprise networking, cloud-managed solutions, and services is enhancing high-margin, recurring revenue streams and supporting sustained margin improvement. Expanded premium home networking portfolio and strengthened cybersecurity positioning are enabling greater market share in both consumer and enterprise segments.
View narrative
US$32.00
FV
15.6% undervalued
intrinsic discount
4.01%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
New
narrative
Vishnu Prakash R Punglia
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Regulatory Delays Will Pressure Margins While Government Tenders Drive Recovery
Key Takeaways Reliance on timely government payments, regulatory scrutiny, and elevated finance costs may suppress margins, earnings, and limit the ability to capitalize on growth opportunities. Geographic concentration and rising competition expose the company to localized risks and potential loss of market share, impacting order inflow and long-term revenue growth.
View narrative
₹131.00
FV
13.3% overvalued
intrinsic discount
19.24%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Astral Foods
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Better South African Crops Will Fuel Poultry Resurgence
Key Takeaways Lower feed costs, rising poultry demand, and expanded production position Astral for margin recovery, increased sales volumes, and earnings growth. Operational efficiencies, technological upgrades, and sector consolidation support improved productivity, cost competitiveness, and enhanced price realization.
View narrative
R233.00
FV
13.8% undervalued
intrinsic discount
3.63%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
New
narrative
Medco Energi Internasional
AN
AnalystConsensusTarget
Consensus Narrative from 12 Analysts
Expanding Gas Portfolio And Renewables Will Shape A Resilient Future
Key Takeaways Expanded gas assets, operational efficiency, and reserve growth support stable cash flow, margin strength, and position Medco to benefit from rising regional energy demand. Investment in renewables and disciplined capital management enhance ESG credentials, earnings resilience, and set the stage for future acquisitions and valuation gains.
View narrative
Rp1.72k
FV
27.8% undervalued
intrinsic discount
0.67%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
27
users have followed this narrative
New
narrative
Universal
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Population Growth And Sustainable Supply Chains Will Support Future Demand
Key Takeaways Rising demand in developing regions and ESG-aligned supply chains support Universal's long-term revenue growth and positioning with global manufacturers. Investments in value-added products, automation, and supply chain efficiency enhance revenue diversification, margin expansion, and profitability.
View narrative
US$72.00
FV
22.4% undervalued
intrinsic discount
0.89%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Value any company in seconds
Popular companies